Reserpine Tablets

Type of Posting: 
Revision Bulletin
Posting Date: 
26–Aug–2011
Official Date: 
01–Sep–2011
Expert Committee: 
Monographs—Small Molecules 2
Reason for Revision: 
Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Reserpine Tablets monograph. The purpose for the revision is to add Dissolution Test 2 for an FDA approved product.

The Reserpine Tablets Revision Bulletin supersedes the currently official Reserpine Tablets monograph. The Revision Bulletin will be incorporated in the First Supplement to USP 35–NF 30.

Should you have any questions, please contact Sujatha Ramakrishna, Ph.D., M.B.A. (301-816-8349 or sxr@usp.org).